Drugs / Fialuridine
Fialuridine
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 2 | NCT00000654 | ? → Feb 1993 | HIV infectious disease, hepatitis B virus infection, herpes simplex infectious disease | National Institute of Allergy and Infectious Diseases (NIAID) | Completed | No outcome recorded |
Evidence & citations 6 cited values
Every value below carries the sentence it was read from. 2 sources stand behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Fialuridine | ClinicalTrials.gov intervention name — accepted as the source's own label NCT00000654 ↗ |
| Known as | Fialuridina | ChEMBL registry synonym — accepted as the source's own label CHEMBL271475 ↗ |
| Known as | Fiau | ChEMBL registry synonym — accepted as the source's own label CHEMBL271475 ↗ |
| Known as | NSC-678514 | ChEMBL registry synonym — accepted as the source's own label CHEMBL271475 ↗ |
| Modality | Small molecule | — CHEMBL271475 ↗ |
| Route | Oral | “TID oral doses of FIAU syrup” NCT00000654 ↗ |